{
  "tier2_001": {
    "description": "Aspirin pKa and Solubility: pKa = 3.49 at 25°C; Solubility at 25°C: Water = 3.3 mg/mL; At 37°C: Water = 6.0 mg/mL",
    "pKa_range": [2.49, 4.49],
    "solubility_ranges": {
      "water_25C": [2.3, 4.3],
      "water_37C": [5.0, 7.0]
    }
  },
  "tier2_002": {
    "description": "Ibuprofen Conformational Analysis: Crystal structure shows extended conformation; pKa = 4.91 ± 0.04; logP = 3.97; Multiple low-energy conformers expected within 2-3 kcal/mol",
    "logP_range": [2.48, 3.97],
    "pKa_range": [4.91, 5.8]
  },
  "tier2_003": {
    "description": "Caffeine Multi-Property Analysis: Aqueous solubility = 21.6 mg/mL at 25°C; Dipole moment = 3.64 D in chloroform; MW = 194.19 g/mol; logP = -0.07",
    "solubility_range": [15.0, 28.0],
    "dipole_moment_range": [3.14, 4.14],
    "logP_range": [-0.57, 0.43]
  },
  "tier3_001": {
    "description": "Warfarin Tautomer-pKa Relationship: pKa = 5.0-5.1 for enolic OH; Exists as cyclic hemiketal (>80%) at physiological pH; Plasma protein binding = 99%; Multiple tautomers in equilibrium",
    "pKa_range": [4.0, 6.1],
    "protein_binding_range": [95, 100]
  },
  "tier3_002": {
    "description": "Acetaminophen Metabolic Sites: Phenolic OH = primary metabolic site for Phase II conjugation; Fukui indices should show highest reactivity at para position to OH; Oral bioavailability = 63-89%; t½ = 1.5-2.5 hours",
    "bioavailability_range": [60, 92],
    "half_life_range": [1.0, 3.0]
  },
  "tier3_003": {
    "description": "Atorvastatin Conformer-Activity: IC50 = 8 nM for HMG-CoA reductase; Crystal structure shows extended conformation with specific H-bonds to Ser684, Asp690, Arg590; Binding energy should correlate with nM potency (ΔG ≈ -11 to -12 kcal/mol)",
    "ic50_range": [4, 16],
    "binding_energy_range": [-13, -10]
  }
}
